These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22048626)

  • 41. A Case of Carcinocythemia: De Novo Hormone Receptor-positive Metastatic Breast Cancer Presenting With Circulating Tumor Cells Mimicking an Acute Leukemia.
    Fratamico RS; Strickland KS; Uppal G; Abu-Khalaf M
    Clin Breast Cancer; 2018 Jun; 18(3):e295-e298. PubMed ID: 28735676
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical value of circulating endothelial cell detection in oncology.
    Kraan J; Sleijfer S; Foekens JA; Gratama JW
    Drug Discov Today; 2012 Jul; 17(13-14):710-7. PubMed ID: 22306349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Advances on breast cancer: a perspective].
    Vera-Román JM
    Med Clin (Barc); 2012 Sep; 139(7):293-4. PubMed ID: 22672964
    [No Abstract]   [Full Text] [Related]  

  • 44. The prognostic value of circulating tumor cells in patients with breast cancer.
    CANDAR Z; RITCHIE AC; HOPKIRK JF; LONG RC
    Surg Gynecol Obstet; 1962 Sep; 115():291-4. PubMed ID: 13876155
    [No Abstract]   [Full Text] [Related]  

  • 45. Pancreatic cancer circulating tumor cells: applications for personalized oncology.
    DiPardo BJ; Winograd P; Court CM; Tomlinson JS
    Expert Rev Mol Diagn; 2018 Sep; 18(9):809-820. PubMed ID: 30099926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating Tumor Cells: Applications for Early Breast Cancer.
    Martos T; Casadevall D; Albanell J
    Adv Exp Med Biol; 2020; 1220():135-146. PubMed ID: 32304084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carcinocythaemia in an advanced stage of invasive ductal carcinoma of the breast.
    Oliver-Caldes A; Gonzalez-Farre B; Merino A; Rozman M
    Br J Haematol; 2019 Apr; 185(1):8. PubMed ID: 30474859
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical utility of measuring circulating tumor cells in metastatic breast cancer.
    Guarneri V; Cristofmilli M
    Clin Breast Cancer; 2006 Apr; 7(1):85-6. PubMed ID: 16764749
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical implications of the detection of circulating tumor cells in breast cancer patients.
    Banys M; Hartkopf AD; Krawczyk N; Becker S; Fehm T
    Biomark Med; 2012 Feb; 6(1):109-18. PubMed ID: 22296204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of circulating tumor DNA in breast cancer.
    Zhao Y; Sheng M; Zheng L; Xiong D; Yang K; Luo Y
    Breast J; 2020 Sep; 26(9):1797-1800. PubMed ID: 32052544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PrediCTC, liquid biopsy in precision oncology: a technology transfer experience in the Spanish health system.
    Alonso-Alconada L; Barbazan J; Candamio S; Falco JL; Anton C; Martin-Saborido C; Fuster G; Sampedro M; Grande C; Lado R; Sampietro-Colom L; Crego E; Figueiras S; Leon-Mateos L; Lopez-Lopez R; Abal M
    Clin Transl Oncol; 2018 May; 20(5):630-638. PubMed ID: 29058262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular mechanisms of metastasis in breast cancer--clinical applications.
    Mego M; Mani SA; Cristofanilli M
    Nat Rev Clin Oncol; 2010 Dec; 7(12):693-701. PubMed ID: 20956980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
    Wang C; Mu Z; Chervoneva I; Austin L; Ye Z; Rossi G; Palazzo JP; Sun C; Abu-Khalaf M; Myers RE; Zhu Z; Ba Y; Li B; Hou L; Cristofanilli M; Yang H
    Breast Cancer Res Treat; 2017 Jan; 161(1):83-94. PubMed ID: 27771841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
    Zhang X; Ju S; Wang X; Cong H
    Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical trials in the era of personalized oncology.
    Maitland ML; Schilsky RL
    CA Cancer J Clin; 2011; 61(6):365-81. PubMed ID: 22034206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review: circulating tumor cells in the practice of breast cancer oncology.
    Ramos-Medina R; Moreno F; Lopez-Tarruella S; Del Monte-Millán M; Márquez-Rodas I; Durán E; Jerez Y; Garcia-Saenz JA; Ocaña I; Andrés S; Massarrah T; González-Rivera M; Martin M
    Clin Transl Oncol; 2016 Aug; 18(8):749-59. PubMed ID: 26646763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [What biomarkers for the future? The point of view of the residents in oncology after the ESMO 2016 Congress].
    Auvray M; Benderra MA; Bretagne M; Faouzi S; Lebellec L; Majhoubi L; Saint-Ghislain M; Vignot S
    Bull Cancer; 2017 Sep; 104(9):744-751. PubMed ID: 28826736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between the spread of circulating tumor cells and breast cancer subtypes.
    Qi X; Yang X; Fan L; Zhang Y; Zhang F; Jiang J
    Breast Cancer Res; 2010; 12(3):402. PubMed ID: 20584343
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical indications for, and the future of, circulating tumor cells.
    Moon DH; Lindsay DP; Hong S; Wang AZ
    Adv Drug Deliv Rev; 2018 Feb; 125():143-150. PubMed ID: 29626548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.